Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by lesflicson Aug 05, 2024 9:53pm
235 Views
Post# 36165285

RE:Being the first PDT treatment...

RE:Being the first PDT treatment...The FDA has approved photodynamic therapy to treat:
Photodynamic therapy is also used to relieve symptoms of some cancers, including:
  •  esophageal cancer when it blocks the throat
  • non-small cell lung cancer when it blocks the airways
Photodynamic Therapy to Treat Cancer

wildbird1 wrote: TLT-Ruvidar is the first PDT treatment to be in a FDA phase11 trial.

When TLT will negotiate a joint venture with a Big Pharma for the first FDA approved PDT treatment,  the selling points for TLT-PDT will be many.

-TLT- PDT can cure patients that Valrubicin, Keytruda, Adstiladrin, CG- Oncology and N803+BCG couldn't cure(FDA approved treatments).
-TLT- PDT cancer treatment has a very high 450 days 37%TR(CR+PR).
-TLT- PDT cancer treatment has no side effects.
-TLT- PDT treatment can cure patients that surgery couldn't cure.
-TLT- PDT cancer treatment can cure patients that Chemotherapy & Radiotherapy couldn't cure.
-TLT- PDT cancer treatment can be adapted to treat many other cancer treatments.
-TLT- PDT treatment can cure patients after only one or two treatments.
- You can also add vaccines to the above.

Note:
Adstiladrin and N803+BCG did get the FDA-BTD approval with 450 days CR% numbers that are lower than TLT-Ruvidar.


For a Big Pharma being the first will implies to always be one step ahead of other future PDT treatments

All the above will add a huge $value to any Big Pharma deals.


I love my TLT shares.




<< Previous
Bullboard Posts
Next >>